vs

Side-by-side financial comparison of GLOBUS MARITIME LTD (GLBS) and Neuphoria Therapeutics Inc. (NEUP). Click either name above to swap in a different company.

Neuphoria Therapeutics Inc. is the larger business by last-quarter revenue ($15.0M vs $9.5M, roughly 1.6× GLOBUS MARITIME LTD). Neuphoria Therapeutics Inc. runs the higher net margin — 75.1% vs -19.6%, a 94.7% gap on every dollar of revenue.

Globus Maritime Ltd is a global shipping enterprise specializing in ownership, operation and chartering of dry bulk cargo vessels. It transports iron ore, coal, grain and other industrial raw materials across major global trade routes, serving clients in logistics, commodities trading and manufacturing sectors worldwide.

Neuphoria Therapeutics Inc is a clinical-stage biopharmaceutical company focused on researching and developing innovative targeted therapies for unmet medical needs in neurological and psychiatric conditions, including anxiety, treatment-resistant depression, and other central nervous system disorders. Its core R&D efforts prioritize delivering safer, more effective treatment options for patient groups with limited existing care alternatives.

GLBS vs NEUP — Head-to-Head

Bigger by revenue
NEUP
NEUP
1.6× larger
NEUP
$15.0M
$9.5M
GLBS
Higher net margin
NEUP
NEUP
94.7% more per $
NEUP
75.1%
-19.6%
GLBS

Income Statement — Q2 FY2025 vs Q3 FY2025

Metric
GLBS
GLBS
NEUP
NEUP
Revenue
$9.5M
$15.0M
Net Profit
$-1.9M
$11.3M
Gross Margin
Operating Margin
-4.3%
79.8%
Net Margin
-19.6%
75.1%
Revenue YoY
0.2%
Net Profit YoY
-157.0%
EPS (diluted)
$-0.09
$6.55

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
GLBS
GLBS
NEUP
NEUP
Q2 25
$9.5M
Q1 25
$15.0M
Q2 24
$9.5M
Q2 23
$7.8M
Q2 22
$19.1M
Net Profit
GLBS
GLBS
NEUP
NEUP
Q2 25
$-1.9M
Q1 25
$11.3M
Q2 24
$3.3M
Q2 23
$-1.2M
Q2 22
$11.0M
Operating Margin
GLBS
GLBS
NEUP
NEUP
Q2 25
-4.3%
Q1 25
79.8%
Q2 24
39.2%
Q2 23
-17.2%
Q2 22
57.8%
Net Margin
GLBS
GLBS
NEUP
NEUP
Q2 25
-19.6%
Q1 25
75.1%
Q2 24
34.5%
Q2 23
-14.8%
Q2 22
57.5%
EPS (diluted)
GLBS
GLBS
NEUP
NEUP
Q2 25
$-0.09
Q1 25
$6.55
Q2 24
$0.16
Q2 23
$-0.06
Q2 22
$0.53

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
GLBS
GLBS
NEUP
NEUP
Cash + ST InvestmentsLiquidity on hand
$48.3M
$17.0M
Total DebtLower is stronger
Stockholders' EquityBook value
$173.1M
$26.0M
Total Assets
$309.4M
$30.7M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
GLBS
GLBS
NEUP
NEUP
Q2 25
$48.3M
Q1 25
$17.0M
Q2 24
$70.8M
Q2 23
$53.2M
Q2 22
$43.6M
Stockholders' Equity
GLBS
GLBS
NEUP
NEUP
Q2 25
$173.1M
Q1 25
$26.0M
Q2 24
$178.9M
Q2 23
$172.1M
Q2 22
$169.5M
Total Assets
GLBS
GLBS
NEUP
NEUP
Q2 25
$309.4M
Q1 25
$30.7M
Q2 24
$256.3M
Q2 23
$217.3M
Q2 22
$206.2M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
GLBS
GLBS
NEUP
NEUP
Operating Cash FlowLast quarter
$11.5M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
1.02×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
GLBS
GLBS
NEUP
NEUP
Q2 25
Q1 25
$11.5M
Q2 24
Q2 23
Q2 22
Cash Conversion
GLBS
GLBS
NEUP
NEUP
Q2 25
Q1 25
1.02×
Q2 24
Q2 23
Q2 22

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

GLBS
GLBS

Other$4.8M51%
Property Plant And Equipment Subject To Operating Leases$4.7M49%

NEUP
NEUP

Segment breakdown not available.

Related Comparisons